BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seifert LL, Schindler P, Schoster M, Weller JF, Wilms C, Schmidt HH, Maschmeier M, Masthoff M, Köhler M, Heinzow H, Wildgruber M. Recurrence of Hepatic Encephalopathy after TIPS: Effective Prophylaxis with Combination of Lactulose and Rifaximin. J Clin Med 2021;10:4763. [PMID: 34682886 DOI: 10.3390/jcm10204763] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wong F. Management of refractory ascites. Clin Mol Hepatol 2023;29:16-32. [PMID: 35676862 DOI: 10.3350/cmh.2022.0104] [Reference Citation Analysis]
2 Gairing SJ, Müller L, Kloeckner R, Galle PR, Labenz C. Review article: post-TIPSS hepatic encephalopathy-current knowledge and future perspectives. Aliment Pharmacol Ther 2022;55:1265-76. [PMID: 35181894 DOI: 10.1111/apt.16825] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Gottlieb A, Canbay A. LOLA zur Standardtherapie der hepatischen Enzephalopathie ergänzen? Gastro-News 2022;9:26-27. [DOI: 10.1007/s15036-022-2453-y] [Reference Citation Analysis]